Literature DB >> 3082414

Serious interaction between cyclosporin A and sulphadimidine.

D K Jones, M Hakim, J Wallwork, T W Higenbottam, D J White.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082414      PMCID: PMC1339782          DOI: 10.1136/bmj.292.6522.728

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  3 in total

1.  Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine.

Authors:  J F Thompson; D H Chalmers; A G Hunnisett; R F Wood; P J Morris
Journal:  Transplantation       Date:  1983-08       Impact factor: 4.939

2.  Sulphamethoxazole, hypoalbuminaemia, crystalluria, and renal failure.

Authors:  N Buchanan
Journal:  Br Med J       Date:  1978-07-15

3.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981
  3 in total
  7 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Heart-lung transplantation for cystic fibrosis.

Authors:  T W Higenbottam; B Whitehead
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

Review 3.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

4.  Heart and lung transplantation in patients with end stage lung disease.

Authors:  A Penketh; T Higenbottam; M Hakim; J Wallwork
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

5.  Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants.

Authors:  A R Penketh; T W Higenbottam; J Hutter; C Coutts; S Stewart; J Wallwork
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

6.  Sulfadiazine therapy for toxoplasmosis in heart transplant recipients decreases cyclosporine concentration.

Authors:  C H Spes; C E Angermann; H U Stempfle; K Wenke; K Theisen
Journal:  Clin Investig       Date:  1992-09

Review 7.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.